Prokinetic Laxatives: How Do They Work And Help?

Prokinetic laxatives are a type of medication used to treat constipation and other gastrointestinal issues. They work by promoting intestinal motility and are typically used for severe constipation associated with irritable bowel syndrome (IBS-C) or chronic idiopathic constipation (CIC). Prokinetics include drugs such as linaclotide, lubiprostone, and castor oil, which act on the intestinal muscles and nerves to stimulate contractions and the passage of stool. They are often used when other treatments, such as lifestyle changes and conventional laxatives, have not been effective. However, prokinetic agents can also have significant side effects, including drowsiness, fatigue, and even serious heart problems, which have led to some being pulled from the market.

Prokinetics are drugs that stimulate contractions in the gastrointestinal tract, helping to move food along

Prokinetics are a class of drugs that stimulate contractions in the gastrointestinal tract, helping to move food along. They are often used to treat severe constipation and are usually considered a second-line treatment option after laxatives.

Prokinetic agents promote intestinal motility and are used to treat severe constipation-predominant symptoms associated with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). They can also be used to empty the bowels before procedures such as colonoscopies.

There are several types of prokinetic drugs, including agonists and antagonists. Agonists mimic the behaviour of certain neurotransmitters, such as acetylcholine, motilin, and serotonin, which stimulate intestinal muscle contractions. Antagonists, on the other hand, prevent certain neurotransmitters from binding to nerves, thereby preventing interference in peristalsis.

Examples of prokinetic agents include:

• Linaclotide
• Lubiprostone
• Castor oil
• Cisapride
• Prucalopride
• Metoclopramide
• Domperidone
• Erythromycin

While prokinetic agents can be effective in treating constipation and improving gut motility, they are also associated with significant side effects, including drowsiness, fatigue, involuntary muscle contractions, and an increased risk of serious heart problems. Therefore, healthcare providers typically prescribe other drugs before considering prokinetics.

They are used to treat gastroparesis, acid reflux, functional dyspepsia, nausea, vomiting, and chronic intestinal pseudo-obstruction

Prokinetic laxatives are used to treat severe constipation, particularly in cases of irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). They are also used to treat gastroparesis, a gut motility disorder characterised by delayed gastric emptying. This condition can cause nausea, vomiting, bloating, and upper abdominal pain.

Prokinetic laxatives can also be used to treat acid reflux, which occurs when the lower oesophageal sphincter (LES) does not function properly. Functional dyspepsia, which is associated with upper abdominal discomfort with no obvious cause, can also be treated with prokinetic laxatives.

Prokinetic agents include cholinergic, motilin, and serotonin agonists, as well as dopamine antagonists

Prokinetic agents are medications that enhance esophageal peristalsis, increase LES pressure, and accelerate gastric emptying. They are used to treat motility disorders of the lower gastrointestinal tract, such as gastroparesis, gastroesophageal reflux, and constipation. Cholinergic agonists, such as bethanechol, improve postoperative ileus but have side effects that limit their use. Dopamine antagonists, such as domperidone, have a maximal prokinetic effect in the proximal gastrointestinal tract and are effective for conditions like gastroparesis and gastroesophageal reflux. They appear to have minimal impact on the colon or colonic motility disorders.

Cholinergic agents act on the neurotransmitter acetylcholine, which is part of the parasympathetic nervous system (PNS). The PNS controls digestion, and cholinergic agonists can improve contractions in the entire GI tract. Bethanechol was once used to treat heartburn and gastroparesis but is now rarely prescribed due to its side effects. Neostigmine and pyridostigmine are alternative cholinergic agonists used for conditions that slow down peristalsis, such as Ogilvie's syndrome and pseudo-obstruction.

Motilin agonists, such as erythromycin, stimulate the motilin receptor on smooth muscle cells and enteric neurons. They can accelerate gastric emptying, enhance coordination between the stomach and duodenum, and stimulate the migrating motor complex. Erythromycin has been used to treat diabetic gastroparesis and improve symptoms of colonic pseudo-obstruction and postoperative ileus. However, long-term antibiotic use is problematic, and the development of antibiotic resistance makes macrolides less suitable as prokinetic agents.

Serotonin agonists work by activating serotonin receptors, another type of neurotransmitter. Cisapride and tegaserod were associated with serious cardiac risks and were withdrawn from the market. Prucalopride, a selective serotonin agonist, is used to treat constipation unresponsive to other treatments and has not shown the same cardiac side effects.

Side effects of prokinetics include drowsiness, fatigue, involuntary muscle contractions, and involuntary facial movements

Prokinetic agents are a class of drugs that promote gut motility by stimulating muscle contractions along the gastrointestinal (GI) tract. They aid in the movement of food from the oesophagus to the stomach and intestines, a process called peristalsis, which also helps the body absorb nutrients. These agents are often used to treat conditions such as gastroparesis, acid reflux, functional dyspepsia, nausea, vomiting, and chronic intestinal pseudo-obstruction.

While prokinetic agents can be beneficial, they also carry significant side effects. Side effects of prokinetics include drowsiness, fatigue, involuntary muscle contractions, and involuntary facial movements. Drowsiness and fatigue can impact an individual's alertness and energy levels, while involuntary muscle contractions can lead to discomfort and impaired movement. Involuntary facial movements may cause distress and affect an individual's ability to communicate or express emotions.

It is important to carefully consider the benefits and risks of prokinetic agents and monitor for any side effects. In some cases, healthcare providers may prescribe alternative medications or recommend non-pharmacological approaches to address digestive issues. Additionally, prokinetic agents should be used with caution, especially if there are concerns about neurological or heart-related side effects.

They are often prescribed alongside proton pump inhibitors or H2 blockers

Prokinetic agents are often prescribed alongside proton pump inhibitors (PPIs) or H2 blockers in the treatment of gastroesophageal reflux disease (GERD). While PPIs and H2 blockers reduce gastric acid secretion, prokinetics promote intestinal motility and improve the motility of the oesophagus and stomach. They also increase the lower oesophageal sphincter (LES) pressure to help reduce the reflux of gastric contents.

Prokinetics are particularly useful in patients with mild symptoms, as most patients with GERD require acid-suppressing medications like PPIs. Long-term use of prokinetic agents may have serious, even potentially fatal, complications and is therefore discouraged.

Prokinetics are also used in conjunction with PPIs to treat small intestinal bacterial overgrowth (SIBO), a condition that can be associated with long-term PPI use.

Frequently asked questions